These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 28436251)
1. Sirolimus coating on heparinized stents prevents restenosis and thrombosis. Bae IH; Lim KS; Park DS; Shim JW; Lee SY; Jang EJ; Park JK; Kim JH; Jeong MH J Biomater Appl; 2017 May; 31(10):1337-1345. PubMed ID: 28436251 [TBL] [Abstract][Full Text] [Related]
2. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis. Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo performance of a dual drug-eluting stent (DDES). Huang Y; Venkatraman SS; Boey FY; Lahti EM; Umashankar PR; Mohanty M; Arumugam S; Khanolkar L; Vaishnav S Biomaterials; 2010 May; 31(15):4382-91. PubMed ID: 20189244 [TBL] [Abstract][Full Text] [Related]
4. Fabrication and characteristics of dual functionalized vascular stent by spatio-temporal coating. Kim SM; Park KS; Lih E; Hong YJ; Kang JH; Kim IH; Jeong MH; Joung YK; Han DK Acta Biomater; 2016 Jul; 38():143-52. PubMed ID: 27109766 [TBL] [Abstract][Full Text] [Related]
5. Hemocompatibility and anti-fouling behavior of multilayer biopolymers immobilized on gold-thiolized drug-eluting cardiovascular stents. Huang LY; Yang MC; Tsou HM; Liu TY Colloids Surf B Biointerfaces; 2019 Jan; 173():470-477. PubMed ID: 30326363 [TBL] [Abstract][Full Text] [Related]
6. The short-term effects on restenosis and thrombosis of echinomycin-eluting stents topcoated with a hydrophobic heparin-containing polymer. Lee YK; Hyung Park J; Tae Moon H; Yun Lee D; Han Yun J; Byun Y Biomaterials; 2007 Mar; 28(8):1523-30. PubMed ID: 17157376 [TBL] [Abstract][Full Text] [Related]
7. The short-term effect on restenosis and thrombosis of a cobalt-chromium stent eluting two drugs in a porcine coronary artery model. Huang Y; Venkatraman SS; Boey FY; Umashankar PR; Mohanty M; Arumugam S J Interv Cardiol; 2009 Oct; 22(5):466-78. PubMed ID: 19627432 [TBL] [Abstract][Full Text] [Related]
8. A Promising Approach for Improving the Coating Stability and In Vivo Performance of Biodegradable Polymer-Coated Sirolimus-Eluting Stent. Bedair TM; Kang SN; Joung YK; Han DK J Biomed Nanotechnol; 2016 Nov; 12(11):2015-28. PubMed ID: 29364616 [TBL] [Abstract][Full Text] [Related]
10. Electrosprayed Montelukast/poly (lactic-co-glycolic acid) particle based coating: A new therapeutic approach towards the prevention of in-stent restenosis. Zamani M; Prabhakaran MP; Varshosaz J; Mhaisalkar PS; Ramakrishna S Acta Biomater; 2016 Sep; 42():316-328. PubMed ID: 27397493 [TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of anti-platelet and anti-inflammation of drug-coated Co-Cr substrates for prevention of initial in-stent restenosis. Lih E; Jung JW; Joung YK; Ahn DJ; Han DK Colloids Surf B Biointerfaces; 2016 Apr; 140():353-360. PubMed ID: 26774572 [TBL] [Abstract][Full Text] [Related]
12. Effect of stents coated with a combination of sirolimus and alpha-lipoic acid in a porcine coronary restenosis model. Lim KS; Park JK; Jeong MH; Bae IH; Nah JW; Park DS; Kim JM; Kim JH; Lee SY; Jang EJ; Jang S; Kim HK; Sim DS; Park KH; Hong YJ; Ahn Y; Kang JC J Mater Sci Mater Med; 2016 Apr; 27(4):66. PubMed ID: 26886814 [TBL] [Abstract][Full Text] [Related]
13. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study. Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728 [TBL] [Abstract][Full Text] [Related]
14. Development of a biodegradable sirolimus-eluting stent coated by ultrasonic atomizing spray. Kim SJ; Park JG; Kim JH; Heo JS; Choi JW; Jang YS; Yoon J; Lee SJ; Kwon IK J Nanosci Nanotechnol; 2011 Jul; 11(7):5689-97. PubMed ID: 22121592 [TBL] [Abstract][Full Text] [Related]
15. Controlled release of paclitaxel from heparinized metal stent fabricated by layer-by-layer assembly of polylysine and hyaluronic acid-g-poly(lactic-co-glycolic acid) micelles encapsulating paclitaxel. Kim TG; Lee H; Jang Y; Park TG Biomacromolecules; 2009 Jun; 10(6):1532-9. PubMed ID: 19361215 [TBL] [Abstract][Full Text] [Related]
16. Dual drug-eluting stents coated with multilayers of hydrophobic heparin and sirolimus. Su LC; Chen YH; Chen MC ACS Appl Mater Interfaces; 2013 Dec; 5(24):12944-53. PubMed ID: 24294944 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating. Wessely R; Hausleiter J; Michaelis C; Jaschke B; Vogeser M; Milz S; Behnisch B; Schratzenstaller T; Renke-Gluszko M; Stöver M; Wintermantel E; Kastrati A; Schömig A Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):748-53. PubMed ID: 15681298 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries. Ge J; Qian J; Wang X; Wang Q; Yan W; Yan Y; Fan B; Ge L; Liu X Catheter Cardiovasc Interv; 2007 Feb; 69(2):198-202. PubMed ID: 17195205 [TBL] [Abstract][Full Text] [Related]
19. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents. Grube E; Buellesfeld L Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588 [TBL] [Abstract][Full Text] [Related]
20. Sirolimus-eluting stent implantation for bare-metal in-stent restenosis: is there any evidence for a late catch-up phenomenon? Sheiban I; Chiribiri A; Galli S; Biondi-Zoccai G; Montorsi P; Beninati S; Fabbiocchi F; Moretti C; Omedè P; Trabattoni D; Lotrionte M; Trevi GP; Bartorelli AL J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):783-8. PubMed ID: 18607241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]